BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18257818)

  • 1. A case report of plasmapheresis treatment in a patient with paraneoplastic cerebellar degeneration and high anti-yo antibody titers.
    Landtblom AM; Lindvall B; Ledin T; Berlin G
    Ther Apher Dial; 2008 Feb; 12(1):82-5. PubMed ID: 18257818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
    Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
    Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case report of plasmapheresis in paraneoplastic cerebellar ataxia associated with anti-Tr antibody.
    Taniguchi Y; Tanji C; Kawai T; Saito H; Marubayashi S; Yorioka N
    Ther Apher Dial; 2006 Feb; 10(1):90-3. PubMed ID: 16556143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
    Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein].
    Tanaka K; Tanaka M; Onodera O; Igarashi S; Tsuji S
    No To Shinkei; 1994 Jan; 46(1):47-51. PubMed ID: 8136199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
    Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin. A case report.
    David YB; Warner E; Levitan M; Sutton DM; Malkin MG; Dalmau JO
    Cancer; 1996 Nov; 78(10):2153-6. PubMed ID: 8918408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma].
    Huober J; Niedermaier N; Drlicek M; Kaufmann M; Hacke W; Bastert G
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):214-6. PubMed ID: 8682288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoimmune paraneoplastic cerebellar degeneration].
    Lövblad KO; Henny C; Boucraut J; Graus F; Delaloye JF; Bernard D; Steck AJ; Regli F
    Rev Neurol (Paris); 1994; 150(1):46-9. PubMed ID: 7801040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
    Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
    PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic cerebellar degeneration with anti-Yo antibody in a patient with HER2/neu overexpressing breast cancer: a case report with a current literature review.
    Ogita S; Llaguna OH; Feldman SM; Blum R
    Breast J; 2008; 14(4):382-4. PubMed ID: 18540952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Purkinje cells antibodies in two cases of paraneoplastic cerebellar degeneration.
    Sindic CJ; Andersson M; Boucquey D; Chalon MP; Bisteau M; Brucher JM; Laterre EC
    Acta Neurol Belg; 1993; 93(2):65-77. PubMed ID: 8506746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma.
    Xia K; Saltzman JR; Carr-Locke DL
    MedGenMed; 2003 Aug; 5(3):18. PubMed ID: 14600654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic tests: Anti-Purkinje cell antibody (Anti-Yo/type 1 antibody)].
    Tanaka K
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():479-82. PubMed ID: 16111307
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
    Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
    Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K; Tanaka M; Onodera O; Tsuji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies.
    Storstein A; Krossnes BK; Vedeler CA
    Acta Neurol Scand; 2009 Jul; 120(1):64-7. PubMed ID: 19486326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical paraneoplastic syndrome associated with anti-Yo antibodies.
    Finsterer J; Bodenteich A; Drlicek M
    Clin Neuropathol; 2003; 22(3):137-40. PubMed ID: 12809356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-Purkinje cell antibody (anti-Yo/type 1 antibody)].
    Tanaka K
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():526-9. PubMed ID: 20942120
    [No Abstract]   [Full Text] [Related]  

  • 20. Paraneoplastic neurological syndrome: patient with anti-Yo antibody and breast cancer: a case report.
    Dorn C; Knobloch C; Kupka M; Morakkabati-Spitz N; Schmolling J
    Arch Gynecol Obstet; 2003 Nov; 269(1):62-5. PubMed ID: 14605824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.